Innovacell Inc.
|
| Code |
Sector |
Market |
Lead Underwriter |
Date of listing approval |
IPO Date |
| 504A |
Pharmaceuticals |
Growth |
Nomura Securities Co., Ltd |
2026/01/19 |
2026/02/24 |
| 【Description】 |
| |
IPO Information |
| Opening Price |
Y1,248 |
Total Amount |
Y14,166,900,000 |
| IPO Price |
Y1,350 |
--Company |
Y10,489,500,000 |
Aggregate Value
(based on Initial Price) |
52,086
(Unit:1 million) |
--Leading Shareholder |
Y2,614,882,500 |
| Listed Shares(total) |
10,494,000 |
--Lead Manager |
Y1,062,517,500 |
| Trading Unit |
100 |
|
Offering Price PER
(based on previous period) |
-15.10 |
Offering Price PBR
(based on previous period) |
-20.91 |
| 公開価格PER(今期予想ベース) |
-14.24 |
| Initial Price PER |
-13.96 |
Initial Price PBR |
-19.33 |
| New Shares |
8,400,000 |
Existing Shares |
2,094,000（incl. O.A.） |
| Shares Outstanding |
Pre IPO |
33,335,702.00 |
PostIPO |
41,735,702.00 |
| Paid Up Capital |
PreIPO |
Y4,131,360,000 |
PostIPO |
Y7,003,672,313 |
| Use of Funds Raised |
|
Financial Data |
| Units:Y1,000 |
| Fiscal Year End |
|
Revenue |
Current Profit |
Net Profit |
Net Assets |
| 2022/12 |
Consolidated |
- |
- |
- |
- |
| Non-consolidated |
- |
-514,321 |
-515,271 |
1,811,061 |
| 2023/12 |
Consolidated |
- |
-2,000,857 |
-2,002,340 |
-1,737,916 |
| Non-consolidated |
- |
-515,539 |
-516,489 |
2,129,572 |
| 2024/12 |
Consolidated |
- |
-2,391,551 |
-2,392,439 |
-1,956,100 |
| Non-consolidated |
- |
-771,949 |
-772,899 |
3,637,134 |
Recent Quarter
2025/09 |
Consolidated |
- |
-2,093,627 |
-2,094,596 |
316,149 |
| Non-consolidated |
- |
- |
- |
- |
Results Forecast
2025/12 |
Consolidated |
- |
-3,040,000 |
-3,041,000 |
- |
| Non-consolidated |
- |
- |
- |
- |
| Per Share |
Units:Y1 |
| Fiscal Year End |
|
Dividend |
Net Earning |
Equity |
|
| 2022/12 |
Consolidated |
0.00 |
- |
- |
|
| Non-consolidated |
-20.64 |
68.13 |
|
| 2023/12 |
Consolidated |
0.00 |
-75.39 |
-96.94 |
|
| Non-consolidated |
-19.45 |
48.68 |
|
| 2024/12 |
Consolidated |
0.00 |
-89.42 |
-64.57 |
|
| Non-consolidated |
-28.89 |
119.89 |
|
| Fiscal Year End |
|
Dividend |
Net Earning |
Equity |
|
Recent Quarter
2025/09 |
Consolidated |
|
-66.18 |
- |
|
| Non-consolidated |
- |
- |
|
Results Forecast
2025/12
| Consolidated
| 0.00 |
-94.81 |
- |
|
| Non-consolidated |
- |
- |
|
Comment |
| ■Over allotment (1,368,700) |
| Consolidated Subsidiaries |
| Name |
Address |
| Underwriters |
| Allocation |
Underwriter |
Tel |
| 92.5% |
Nomura Securities Co., Ltd |
03-3211-1811 |
| 7.5% |
SBI SECURITIES Co.,Ltd. |
03-5562-7210 |
| Data |
| Date of incorporation |
2021/01/05 |
| Company address |
Tokyo 141-0021 |
| Telephone |
03-6555-4437 |
| President |
|
| Homepage |
https://www.innovacell.co.jp/ |
| Auditor |
Avantia GP |
|
|
| Major Shareholders |
| Shareholder Name |
Ratio |
| |
9.45% |
| |
9.45% |
| |
6.45% |
| |
6.36% |
| |
6.36% |
| |
6.16% |
| |
6.08% |
| |
4.31% |
| |
3.51% |
| |
3.08% |
| Number of Employees |
13 as of 2025/11/30 |
| Birth Date of Representative |
1981/04/03 |
|
|
IPO最新情報、セミナー・イベント情報などをタイムリーにお届けします。
|
|
IPO関連ニュースをX（旧Twitter）でも掲載中。初値予想アンケートも実施中です！
|
|
今後の躍進が期待される注目銘柄のアナリストレポートをご覧いただけます。
|
|
個人投資家向けIRセミナーを開催しませんか？開催希望企業募集中！
|
|
